Sunday 27 Apr, 2025 11:54 AM
Site map | Locate Us | Login
   Kamat Hotels Q4 PAT surges 412% YoY to Rs 11 cr    Bank of Maharashtra Q4 PAT climbs 23% YoY to Rs 1,493 crore    Oracle Financial Services Software Q4 PAT up 19% QoQ    Force Motors Q4 PAT surges 210% YoY to Rs 435 cr; declares dividend of Rs 40/sh    RBL Bank PAT drops 81% YoY to Rs 69 crore in Q4 FY25; provisions zoom by 90% YoY    Tejas Networks reports dismal Q4 outcome    Zydus Life gets 6 observations from USFDA for API plant    RIL Q4 PAT rises 6.4% YoY    Tata Technologies Q4 PAT climbs 12% QoQ to Rs 189 cr    VST Inds slides after Q4 PAT slumps 42% YoY to Rs 67 cr; declares dividend of Rs 10/sh    Atul gains after Q4 PAT soars 117% YoY; declares dividend of Rs 25/sh    Orient Electric Q4 PAT soars 144% YoY to Rs 31 crore    Oriental Hotels PAT rises 8% YoY in Q4 FY25    VST Industries Ltd leads losers in 'A' group    SRM Contractors Ltd leads losers in 'B' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Emcure Pharma's pune facility receives VAI status from USFDA
21-Apr-25   11:09 Hrs IST

The company received the Establishment Inspection Report (EIR) from the USFDA following an inspection conducted between 19 February 2025 and 25 February 2025. According to an exchange filing dated 26 February 2025, the inspection concluded with the issuance of two observations in Form 483.

Pune-based Emcure Pharmaceuticals is a leading Indian pharma company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products.

The company's consolidated net profit surged 35.5% to Rs 153.72 crore in Q3 FY25 as against Rs 113.45 crore posted in Q3 FY24. Revenue from operations jumped 17.7% YoY to Rs 1,962.63 crore in the quarter ended 31 December 2024.

The scrip shed 0.89% to Rs 1,084.95 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40477709
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd